Elicitation of Neutralizing Antibodies Directed against CD4-Induced Epitope(s) Using a CD4 Mimetic Cross-Linked to a HIV-1 Envelope Glycoprotein-Reference-Cited by-同舟云学术

Elicitation of Neutralizing Antibodies Directed against CD4-Induced Epitope(s) Using a CD4 Mimetic Cross-Linked to a HIV-1 Envelope Glycoprotein

Published:2012-01-24 Issue:1 Volume:7 Page:e30233
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dey Antu K.,Burke Brian,Sun Yide,Sirokman Klara,Nandi Avishek,Hartog Karin,Lian Ying,Geonnotti Anthony R.,Montefiori David,Franti Michael,Martin Grégoire,Carfi Andrea,Kessler Pascal,Martin Loïc,Srivastava Indresh K.,Barnett Susan W.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference71 articles.

1. Toward an AIDS vaccine.;BD Walker;Science,2008

2. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.;LM Walker;Science,2009

3. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.;A Trkola;J Virol,1996

4. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.;DR Burton;Science,1994

5. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.;X Wu;Science

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors;Current Opinion in HIV and AIDS;2020-09

2. Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates;Journal of Virology;2018-03

3. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques;Journal of Virology;2017-10

4. Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa;PLOS ONE;2016-07-21

5. Env–2dCD4S60C complexes act as super immunogens and elicit potent, broadly neutralizing antibodies against clinically relevant human immunodeficiency virus type 1 (HIV-1);Vaccine;2015-11